A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)
- Status
- COMPLETED
- Phase
- PHASE3
Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE4
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
- Status
- COMPLETED
- Phase
- PHASE2
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE3
The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
- Status
- COMPLETED
- Phase
- N/A
Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
- Status
- COMPLETED
- Phase
- PHASE1
Intranasal Bevacizumab for HHT-Related Epistaxis
- Status
- COMPLETED
- Phase
- PHASE4
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
- Status
- TERMINATED
- Phase
- PHASE2
INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1